Table 3.
Comparison of MTM Delivery to Beneficiaries Receiving CMRs by Community Pharmacists and Other Pharmacist Provider Types in 2014
| 104,303 (100%) | |||||
|---|---|---|---|---|---|
| CMR Provided By: | |||||
| Community RPh n (%) |
Plan RPh n (%) |
p-value† | MTM Vendor In-House RPh n (%) |
p-value‡ | |
| Total Beneficiaries by Provider Status | 26,337 (25.3%) | 35,741 (34.3%) | 42,225 (40.5%) | ||
| Entry into MTM Program | |||||
| Days from Plan Enrollment to MTM Enrollment | |||||
| Mean | 68.4 (78) | 72.9 (83) | 79.5 (78) | ||
| Median | 31 | 48 | <0.001c | 33 | <0.001d |
| 25th Percentile | 0 | 0 | 26 | ||
| 75th Percentile | 100 | 111 | 119 | ||
| Days from MTM Enrollment to CMR Offer, n (%) | |||||
| Mean (SD) | 30.5 (33) | 17.8 (29) | 20.4 (20) | ||
| Median | 28 | 9 | <0.001§ | 16 | <0.001¶ |
| 25th Percentile | 9 | 0 | 4 | ||
| 75th Percentile | 38 | 26 | 28 | ||
| 0 | 174 (0.7%) | 11,071 (31.0%) | 1,004 (2.4%) | ||
| 1–30 | 16,757 (63.6%) | 18,394 (51.5%) | 32,157 (76.2%) | ||
| 31–60 | 7915 (30.1%) | 5004 (14.0%) | 7757 (18.4%) | ||
| 61+ | 1491 (5.7%) | 1263 (3.5%) | 1178 (2.8%) | ||
| Unknown | 0 (0.0%) | 9 (0.0%) | 129 (0.3%) | ||
| Days from CMR Offer to First CMR Received | |||||
| Mean | 85.5 (86) | 101.4 (85) | 116.6 (93) | ||
| Median | 47 | 76 | <0.001§ | 94 | <0.001¶ |
| 25th Percentile | 20 | 32 | 31 | ||
| 75th Percentile | 140 | 155 | 194 | ||
| Part D Contract Type, n (%) | 0.394 | <0.001 | |||
| Managed Care | 19,643 (74.6%) | 26,543 (74.3%) | 19,734 (46.7%) | ||
| Prescription Drug Plan | 6690 (25.4%) | 9188 (25.7%) | 22,323 (52.9%) | ||
| Employer Sponsored | 4 (0.0%) | 10 (0.0%) | 168 (0.4%) | ||
| MTM Services Received | |||||
| CMR Delivery Method, n (%) | <0.001 | <0.001 | |||
| Face-to-Face | 13,010 (49.4%) | 380 (1.1%) | 9 (0.0%) | ||
| Telephone | 13,327 (50.6%) | 35,361 (98.9%) | 42,216 (100.0%) | ||
| Telehealth Consultation (Video Conferencing) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | ||
| CMR Recipient | <0.001 | <0.001 | |||
| Beneficiary | 23,281 (88.4%) | 32,261 (90.3%) | 36,246 (85.8%) | ||
| Beneficiary’s Prescriber | 53 (0.2%) | 7 (0.0%) | 14 (0.0%) | ||
| Caregiver/Other Authorized Individual | 3003 (11.4%) | 3473 (9.7%) | 5965 (14.1%) | ||
| Mean Number of CMRs Received (SD) | 1.01 (0.1) | 1.02 (0.1) | <0.001 | 1.03 (0.2) | <0.001 |
| Mean Number of Targeted Medication Reviews (SD) | 10.29 (8.9) | 5.71 (6.7) | <0.001 | 18.36 (18) | <0.001 |
| MTM Interventions Made | |||||
| Mean Number of MTP Recommendations Made to Prescribers (SD) | 1.80 (3.5) | 1.17 (2.5) | <0.001 | 1.64 (2.8) | <0.001 |
| Mean Number of MTP Resolutions With Prescribers (SD) | 0.22 (0.7) | 0.33 (0.9) | <0.001 | 0.35 (0.8) | <0.001 |
CMR = comprehensive medication review; MTM = Medication Therapy Management; MTP = medication therapy problem; RPh = pharmacist; SD = standard deviation.
P-values represent comparisons using t-tests (continuous variables) or chi-square tests (categorical variables) between community pharmacist and plan pharmacist cohorts.
P-values represent comparisons using t-tests (continuous variables) or chi-square tests (categorical variables) between community pharmacist and MTM Vendor In-house pharmacist cohorts.
P-values represent comparisons using Wilcoxon rank sum tests between community pharmacist and plan pharmacist cohorts.
P-values represent comparisons using Wilcoxon rank sum tests between community pharmacist and MTM Vendor In-house pharmacist cohorts.